Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Neurocrine Biosciences (NBIX) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Monday, January 13, 2025, at 8:15 a.m. Pacific Time.

Chief Executive Officer Kyle Gano will deliver the company's presentation, which will be accessible through a live webcast on the company's website under the Investors section at www.neurocrine.com. For those unable to attend the live event, a replay will be made available approximately one hour after the presentation concludes and will remain accessible for about one month.

SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 43^rd Annual J.P. Morgan Healthcare Conference at 8:15 a.m. Pacific Time on Monday January 13, 2025 in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference.

The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X (formerly Twitter) and Facebook. (*in collaboration with AbbVie)

The NEUROCRINE BIOSCIENCES Logo Lockup and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302343441.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

When is Neurocrine Biosciences (NBIX) presenting at the 2025 J.P. Morgan Healthcare Conference?

Neurocrine Biosciences is presenting on Monday, January 13, 2025, at 8:15 a.m. Pacific Time.

How can investors watch NBIX's presentation at the J.P. Morgan Healthcare Conference?

Investors can watch the live webcast through Neurocrine's website under the Investors section at www.neurocrine.com.

How long will NBIX's J.P. Morgan Healthcare Conference presentation replay be available?

The presentation replay will be available on the company's website for approximately one month after the event.

Who will be presenting for NBIX at the 2025 J.P. Morgan Healthcare Conference?

Kyle Gano, Chief Executive Officer of Neurocrine Biosciences, will be presenting at the conference.

When will the replay of NBIX's J.P. Morgan Healthcare Conference presentation become available?

The replay will be available approximately one hour after the conclusion of the presentation.